Publications by authors named "Stephane Hominal"

Claim this Profile
F
First-Line Pembrolizumab Efficacy in Octogenarians With NSCLCs Expressing ≥ 50% PD-L1 (ESCKEYP GFPC 05-2018).
Romain Corre, Chantal Decroisette, Jean-Bernard Auliac, Lionel Falchero, Hubert Curcio, Stéphane Hominal

Clin Lung Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LIBELULE: A Randomized Phase III Study to Evaluate the Clinical Relevance of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer.
Aurélie Swalduz, Camille Schiffler, Hubert Curcio, Bana Ambasager, Gabriel Le Moel, Stéphane Hominal

J Thorac Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08-2015 ENERGY): a randomised, open-label, phase 3 study.
Hervé Léna, Laurent Greillier, Claire Cropet, Olivier Bylicki, Isabelle Monnet, Stéphane Hominal

Lancet Respir Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life nationwide characteristics and outcomes of small cell lung cancer over the last 20 years: Impact of immunotherapy on overall survival in a real-life setting.
Lionel Falchero, Nicolas Meyer, Olivier Molinier, Faraj Al Freijat, Hervé Pegliasco, Stéphane Hominal

Eur J Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04-2021) trial.
Olivier Bylicki, Florian Guisier, Arnaud Scherpereel, Catherine Daniel, Aurélie Swalduz, Stephane Hominal

Lung Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo).
Alain Vergnenegre, Isabelle Monnet, Charles Ricordel, Acya Bizieux, Hubert Curcio, Stéphane Hominal

Lung Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of an eHealth (NOMHAD) System Comprising Telemonitoring, Telenotification, and Telecoaching for Patients With Multimorbidity: Proof-of-Concept Study.
Mathieu Chacornac, Aurélien Faoro, Joëlle Texereau, Catherine Billoet, Stéphane Hominal

JMIR Form Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: a prospective multicenter study in a real-world setting (GFPC study 12-01).
Christos Chouaid, Cecile Dujon, Pascal Do, Isabelle Monnet, Anne Madroszyk, Stephane Hominal

Lung Cancer· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of palliative care for advanced non-small-cell lung cancer in France: a prospective observational multicenter study (GFPC 0804 study).
Alain Vergnenègre, Stéphane Hominal, Achille Edem Tchalla, Henri Bérard, Isabelle Monnet

Lung Cancer· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly paclitaxel combined with monthly carboplatin in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study.
Jean-Louis Pujol, Bernard Milleron, Olivier Molinier, Elisabeth Quoix, Alain Depierre, Stéphane Hominal

J Thorac Oncol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
Line Claude, David Pérol, Chantal Ginestet, Lionel Falchero, Dominique Arpin, Stéphane Hominal

Radiother Oncol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exogenous lipoid pneumonia with unusual CT pattern and FDG positron emission tomography scan findings.
Florence Tahon, Yves Berthezène, Stephane Hominal, Nadine Blineau, Jean-Claude Guérin

Eur Radiol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis